Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Venice Chávez‐Valencia

ResearcherPublications, citations & collaboration network

Venice Chávez‐Valencia is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 27 works, 608 citations, an h-index of 9 and an i10-index of 9.

27
Works
608
Citations
9
h-index
9
i10-index

How has Venice Chávez‐Valencia's publication output changed over time?

ScholarIQpublication output · 2010–2025

Output grew0% over the shown period — from 1 works in 2010 to 1 in 2025.

1
1
4
2
1
1
1
2010201420172020202120222025

What are the most-cited papers on Venice Chávez‐Valencia?

ScholarIQmost cited works
High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients
Francisco Alejandro Lagunas‐Rangel, Venice Chávez‐Valencia
S49828768. 2020170 CitationsOPEN ACCESS
Acute Myeloid Leukemia-Genetic Alterations and Their Clinical Prognosis.
Francisco Alejandro Lagunas‐Rangel, Venice Chávez‐Valencia, Miguel Ángel Gómez‐Guijosa, Carlos Cortés‐Penagos
PubMed. 2017147 CitationsOPEN ACCESS
FLT3–ITD and its current role in acute myeloid leukaemia
Francisco Alejandro Lagunas‐Rangel, Venice Chávez‐Valencia
S204953464. 2017124 Citations
Learning of nature: The curious case of the naked mole rat
Francisco Alejandro Lagunas‐Rangel, Venice Chávez‐Valencia
Mechanisms of Ageing and Development. 201737 Citations
What do we know about the antibody responses to SARS-CoV-2?
Francisco Alejandro Lagunas‐Rangel, Venice Chávez‐Valencia
S164377831. 202130 CitationsOPEN ACCESS

Related on ScholarIQ

Mexican Social Security Institute
Institution
High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients
Paper
Acute Myeloid Leukemia-Genetic Alterations and Their Clinical Prognosis.
Paper
FLT3–ITD and its current role in acute myeloid leukaemia
Paper
Learning of nature: The curious case of the naked mole rat
Paper
What do we know about the antibody responses to SARS-CoV-2?
Paper
470M+ articles · free account